CXCR2 Inhibitors:阻害薬のグローバル市場2014(薬開発、治験動向)

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DIMR2014208)
◆英語タイトル:CXCR2 Inhibitors -Pipeline Insights, 2014
◆発行会社/調査会社:DelveInsight
◆商品コード:DIMR2014208
◆発行日:2014年版(※最新版はお問い合わせください)
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:25以上
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD1,250 ⇒換算¥136,250見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,500 ⇒換算¥272,500見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD4,000 ⇒換算¥436,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[CXCR2 Inhibitors:阻害薬のグローバル市場2014(薬開発、治験動向)]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

DelveInsight’s,“CXCR2 Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under CXCR2 Inhibitors. This report provides information on the therapeutic development based on the CXCR2 Inhibitors dealing with mechanism of action, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.
Data Sources

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated mechanism of action.


• The report provides a snapshot of the global therapeutic landscape of CXCR2 Inhibitors
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the CXCR2 Inhibitors pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for CXCR2 Inhibitors and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

• Complete MOA intelligence and complete understanding over therapeutics development for CXCR2 Inhibitors
• Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
• Devise corrective measures for pipeline projects by understanding CXCR2 Inhibitors pipeline depth and focus of Indication therapeutics
• Developing strategic initiatives to support your drug development activities.
• Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
• Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
• Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
• Gaining a Full Picture of the Competitive Landscape for Evidence based Decisions

*** レポート目次(コンテンツ)***

• CXCR2 Inhibitors Overview
• CXCR2 Inhibitors Disease Associated
• CXCR2 Inhibitors Pipeline Therapeutics
• CXCR2 Inhibitors Therapeutics under Development by Companies
• CXCR2 Inhibitors Late Stage Products (Filed and Phase III)
• Comparative Analysis
• CXCR2 Inhibitors Mid Clinical Stage Products (Phase II)
• Comparative Analysis
• CXCR2 Inhibitors Early Clinical Stage Products (Phase I and IND Filed)
• Comparative Analysis
• CXCR2 Inhibitors Discovery and Pre-Clinical Stage Products
• Comparative Analysis
• Drug Candidate Profiles
• CXCR2 Inhibitors – Therapeutics Assessment
• Assessment by Monotherapy Products
• Assessment by Combination Products
• Assessment by Route of Administration
• Assessment by Molecule Type
• CXCR2 Inhibitors – Discontinued Products
• CXCR2 Inhibitors – Dormant Products
• Companies Involved in Therapeutics Development for CXCR2 Inhibitors
• Appendix
• Methodology
• Contact Us
• Disclaimer

• Number of Products under Development for CXCR2 Inhibitors by Therapy Area, 2014
• Number of Products under Development for CXCR2 Inhibitors, 2014
• Number of Products under Development by Companies
• Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2014
• Comparative Analysis Mid Clinical Stage Products (Phase II), 2014
• Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2014
• Comparative Analysis Discovery and Pre-Clinical Stage Products, 2014
• Drug Candidates Profiles
• CXCR2 Inhibitors Assessment by Monotherapy Products
• CXCR2 Inhibitors Assessment by Combination Products
• CXCR2 Inhibitors Assessment by Route of Administration
• CXCR2 Inhibitors Assessment by Stage and Route of Administration
• CXCR2 Inhibitors Assessment by Molecule Type
• CXCR2 Inhibitors Assessment by Stage and Molecule Type
• CXCR2 Inhibitors Therapeutics – Discontinued Products
• CXCR2 Inhibitors Therapeutics – Dormant Products
• Products under Development by Companies, 2014

• Number of Products under Development for CXCR2 Inhibitors by Therapy Area, 2014
• Number of Products under Development for CXCR2 Inhibitors, 2014
• Late Clinical Stage Products (Filed and Phase III), 2014
• Mid Clinical Stage Products (Phase II), 2014
• Early Clinical Stage Products (Phase I and IND Filed), 2014
• Discovery and Pre-Clinical Stage Products, 2014
• CXCR2 Inhibitors Assessment by Monotherapy Products
• CXCR2 Inhibitors Assessment by Combination Products
• CXCR2 Inhibitors Assessment by Route of Administration
• CXCR2 Inhibitors Assessment by Stage and Route of Administration
• CXCR2 Inhibitors Assessment by Molecule Type
• CXCR2 Inhibitors Assessment by Stage and Molecule Type

*** レポートのキーワード ***

薬剤、医薬品、製薬企業、試験、作用機序(MOA)、パイプライン、開発

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • トウモロコシ種子の世界市場2021
    This report studies Corn Seed in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with sales, price, revenue and market share for each manufacturer, covering Monsanto Dupont Pioneer Syngenta Limagrain Dow KWS I …
  • 建設機械・鉱山機械市場(~2018):デンマーク(市場規模、動向、予測)
    This industry report offers the most up-to-date market data on the actual market situation, trends and future outlook for construction and mining machinery in Denmark. The research includes historic market data from 2007 to 2013 and forecasts until 2018 which makes the report an invaluable resource …
  • ガーナのブルドーザー及びアングルドーザ市場(~2020):市場規模、動向、予測
    The report Bulldozer and Angledozer Market in Ghana to 2020 - Market Size, Development, and Forecasts offers the most up-to-date industry data on the actual market situation, and future outlook for bulldozers and angledozers in Ghana. The research includes historic data from 2009 to 2015 and forecas …
  • ゼロ・エネルギー・ビルの世界市場2015-2019
    About Zero Energy Buildings Zero energy buildings consume only as much energy as they generate within a year. Green building practices are becoming more common in the global construction industry. With increasing energy costs and growing GHG emissions, both residential and commercial and public buil …
  • Electricity Supply Board:企業概要、戦略的SWOT分析
    Electricity Supply Board - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • カナダの微生物培養装置市場
    Canada Microbiology Culture Market Outlook to 2021 Summary GlobalData’s new report, "Canada Microbiology Culture Market Outlook to 2021", provides key market data on the Canada Microbiology Culture market. The report provides value, in millions of US dollars within market segments - Microbiology Ana …
  • 韓国のインターナル・クレンザー&スプレー(女性衛生)市場:市場規模、成長、予測
    SummaryInternal Cleansers and Sprays are usually liquid solutions / wipes infused with antiseptic chemicals and/or aloe vera and are used to clean a woman's genitals and/or anal tracts. Their application prevents dryness, rashes, odor or itching sensation internally. Sprays help prevent odor and bri …
  • 世界及び中国のUVグレージングオイル市場2017
    The 'Global and Chinese UV Glazing Oil Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global UV Glazing Oil industry with a focus on the Chinese market. The report provides key statistics on the market status of the UV Glazing Oil manufac …
  • ロシアの塩化ビニルモノマー(VCM)市場(~2019):市場規模、シェア、動向
    Vinyl Chloride Monomer (VCM) Industry Outlook in Russian Federation to 2019 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalData’s new report, "Vinyl Chloride Monomer (VCM) Industry Outlook in Russian Federation to 2019 - Market Size, Com …
  • RFIDスマート・アンテナの世界市場2016-2020
    About the RFID Smart Antenna Market An RFID system is a wireless technology that uses radio waves to receive data from a tag attached to an object. It is used for various purposes such as tracking objects and automatic identification. Components of RFID systems are as follows: • Tag (attached to an …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DIMR2014208 )"CXCR2 Inhibitors:阻害薬のグローバル市場2014(薬開発、治験動向)" (英文:CXCR2 Inhibitors -Pipeline Insights, 2014)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。